PLoS ONE
(Jan 2023)
Correction: Prediction of outcome in patients with non-small cell lung cancer treated with second line PD-1/PDL-1 inhibitors based on clinical parameters: Results from a prospective, single institution study.
Konstantinos Rounis,
Dimitrios Makrakis,
Chara Papadaki,
Alexia Monastirioti,
Lambros Vamvakas,
Konstantinos Kalbakis,
Krystallia Gourlia,
Iordanis Xanthopoulos,
Ioannis Tsamardinos,
Dimitrios Mavroudis,
Sofia Agelaki
Affiliations
Konstantinos Rounis
Dimitrios Makrakis
Chara Papadaki
Alexia Monastirioti
Lambros Vamvakas
Konstantinos Kalbakis
Krystallia Gourlia
Iordanis Xanthopoulos
Ioannis Tsamardinos
Dimitrios Mavroudis
Sofia Agelaki
DOI
https://doi.org/10.1371/journal.pone.0294382
Journal volume & issue
Vol. 18,
no. 11
p.
e0294382
Abstract
Read online
[This corrects the article DOI: 10.1371/journal.pone.0252537.].
WeChat QR code
Close